People might attribute midnight bouts of chest pain or waves of nausea to food poisoning, stress or a stubborn case of indigestion, but Rutgers Health researchers suggest that knowing your family's ...

The National Institute for Health and Care Excellence (NICE) has recommended durvalumab (IMFINZI, AstraZeneca) with gemcitabine and cisplatin as an option for treating locally advanced, unresectable, ...

Please provide your email address to receive an email when new articles are posted on . Researchers reported a 41% confirmed ORR among patients with HER2-positive disease. No patients with ...

Credit: Jazz Pharmaceuticals Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor. Findings showed the ORR was 52% (95% CI, 39-65), of which ...

Keytruda, combined with gemcitabine and cisplatin, is approved for advanced biliary tract cancer, showing a 17% reduction in death risk compared to chemotherapy alone. The KEYNOTE-966 trial indicated ...

In patients with primary sclerosing cholangitis, biliary tract cancer is the leading cause of death. Yet very little is known about effective systemic treatments in these individuals. A new study ...

The liver produces bile, which the intestine uses for digestion. For the transport of bile, the liver relies on a network of microscopic tubings, known as bile canaliculi, formed by liver cells called ...

Bile duct cysts are atypical enlargements that develop within your biliary system. They may disrupt the normal flow of bile from the gallbladder and liver to your small intestine. Bile duct growths ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old now impacted by the disease. However, despite this, knowledge about these ...